Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIGITALX LIMITED Director's Dealing 2021

May 20, 2021

64762_rns_2021-05-20_a91b3d69-b17d-43d4-b21f-e6c666f36d8d.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity DigitalX Limited
ABN 59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Toby Albert Hicks
Date of last notice 22 March 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Emboodhu Pty Ltd as trustee for the TA and EL
Hicks Family Trust of which Mr Hicks is a Director
and beneficiary of the trust.
Date of change 21 May 2021
No. of securities held prior to change Indirect
8,194,444 Fully Paid Ordinary Shares1
2,500,000 Unlisted Options exercisable at $0.10
each on or before 30 June 20241.
1.
Securities held by Emboodhu Pty Ltd as trustee for
the TA and EL Hicks Family Trust of which Mr Hicks
is a Director and beneficiary of the trust.
Class Fully Paid Ordinary Shares
Number acquired 156,348 Fully Paid Ordinary Shares
Number disposed Nil
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Deemed issue price of $0.048 per Share
No. of securities held after change Indirect
8,350,792 Fully Paid Ordinary Shares1
2,500,000 Unlisted Options exercisable at $0.10
each on or before 30 June 20241.
1.
Securities held by Emboodhu Pty Ltd as trustee for
the TA and EL Hicks Family Trust of which Mr Hicks
is a Director and beneficiary of the trust.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Issue of Fully Paid Ordinary Shares in lieu of cash
remuneration, as approved by Shareholders at
the Annual General Meeting on 26 November
2020.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 311] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
----- End of picture text -----

Part 3 –[+] Closed period

==> picture [429 x 42] intentionally omitted <==

----- Start of picture text -----

Were the interests in the securities or contracts detailed No
above traded during a [+] closed period where prior written
clearance was required?
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity DigitalX Limited
ABN 59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Leigh Daniel Travers
Date of last notice 31 March 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
N/A
Date of change 21 May 2021
No. of securities held prior to change Direct
10,000,000 Fully Paid Ordinary Shares.
9,000,000
Performance
Rights,
subject
to
performance-based
vesting
conditions,
and
expiring 10 December 2023.
Indirect
5,000,000 Fully Paid Ordinary Shares.1
1. Held by Leethal Pty Ltd, an entity associated with Mr
Travers.
Class Fully Paid Ordinary Shares
Number acquired 191,120 Fully Paid Ordinary Shares
Number disposed Nil
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Deemed issue price of $0.048 per Share.
No. of securities held after change Direct
10,191,120 Fully Paid Ordinary Shares.
9,000,000
Performance
Rights,
subject
to
performance-based
vesting
conditions,
and
expiring 10 December 2023.
Indirect
5,000,000 Fully Paid Ordinary Shares.1
1. Held by Leethal Pty Ltd, an entity associated with Mr
Travers.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Issue of Fully Paid Ordinary Shares in lieu of cash
remuneration, as approved by Shareholders at
the Annual General Meeting on 26 November
2020.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which interest
related prior to change.
Note: Details are only required for a contract in relation to which the
interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated
valuation
Interest after change

Part 3 –[+] Closed period

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the
trade to proceed during this period?
If prior written clearance was provided, on what date was
this provided?
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity DigitalX Limited
ABN 59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Peter Irwin Rubinstein
Date of last notice 1 April 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Irwin Biotech Nominees Pty Ltd ATF BIOA Trust.
Peter Irwin Rubinstein is the sole director and
shareholder of Irwin Biotech Nominees Pty Ltd
and sole member of BIOA Trust.
Date of change 21 May 2021
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change Direct
617,284 Fully Paid Ordinary Shares
Indirect
16,196,296 Fully Paid Ordinary Shares1
8,470,000 Fully Paid Ordinary Shares2
3,694,444 Fully Paid Ordinary Shares3
7,200,000 Fully Paid Ordinary Shares4
1,000,000 Unlisted Options exercisable at $0.22
each on or before 10 December 20231
1,500,000 Unlisted Options exercisable at $0.25
each on or before 10 December 20231
2,000,000 Unlisted Options exercisable at $0.30
each on or before the date 10 December 20231
1. Held by Irwin Biotech Nominees Pty Ltd.
2. Held by Irwin Biotech Nominees Pty Ltd ATF BIOA
Trust
3. Held by RIP Opportunities Pty Ltd ATF PIR Super
Fund
4. Held by ValueAdmin.Com Pty Ltd
Class Fully Paid Ordinary Shares
Number acquired 156,348 Fully Paid Ordinary Shares
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
Deemed issue price of $0.048 per Share
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change Direct
617,284 Fully Paid Ordinary Shares
Indirect
16,196,296 Fully Paid Ordinary Shares1
8,626,348 Fully Paid Ordinary Shares2
3,694,444 Fully Paid Ordinary Shares3
7,200,000 Fully Paid Ordinary Shares4
1,000,000 Unlisted Options exercisable at $0.22
each on or before 10 December 20231
1,500,000 Unlisted Options exercisable at $0.25
each on or before 10 December 20231
2,000,000 Unlisted Options exercisable at $0.30
each on or before the date 10 December 20231
1. Held by Irwin Biotech Nominees Pty Ltd.
2. Held by Irwin Biotech Nominees Pty Ltd ATF BIOA
Trust
3. Held by RIP Opportunities Pty Ltd ATF PIR Super
Fund
4. Held by ValueAdmin.Com Pty Ltd
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-
back
Issue of Fully Paid Ordinary Shares in lieu of cash
remuneration, as approved by Shareholders at
the Annual General Meeting on 26 November
2020.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
  • See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the
trade to proceed during this period?
If prior written clearance was provided, on what date was
this provided?
  • See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011